Simple Summary Tumor biomarkers are molecules at genetic or protein level, or certain
evaluable characteristics. These help in perfecting patient management. Over the past …

Background: Recent advances in research on thyroid carcinogenesis have yielded
applications of diagnostic molecular biomarkers and profiling panels in the management of …

The previous edition of The Bethesda System for Reporting Thyroid Cytopathology provided
important updates and advances in the practice of thyroid cytopathology. It was inspired by …

Aims The distinction between benign and malignant thyroid nodules has important
therapeutic implications. Our objective was to develop an assay that could classify …

Optimal management of patients with thyroid cancer requires the use of sensitive and
specific biomarkers. For early diagnosis and effective follow‐up, the currently available …

Context.—Approximately 15% to 30% of thyroid nodules that undergo fine-needle aspiration
are classified as cytologically indeterminate, presenting management challenges for …

MicroRNAs (miRNAs) have emerged as a class of powerful gene expression regulators.
Acting at the post-transcriptional level, miRNAs modulate the expression of at least one-third …

Background: Follicular variant of papillary thyroid carcinoma (FVPTC) shares features of
papillary (PTC) and follicular (FTC) thyroid carcinomas on a clinical, morphological, and …

Abstract MicroRNA-183 (miR-183) family is proposed as promising biomarkers for early
cancer detection and accurate prognosis as well as targets for more efficient treatment. The …

Thyroid nodules are common in the adult population where a majority are benign and only
4.0% to 6.5% are malignant. Fine needle aspiration (FNA) is a key method used in the early …